Next Article in Journal
Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer
Next Article in Special Issue
Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial
Previous Article in Journal
The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia
Previous Article in Special Issue
A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III)
 
 
Review

Article Versions Notes

Cancers 2021, 13(18), 4520; https://doi.org/10.3390/cancers13184520
Action Date Notes Link
article xml file uploaded 8 September 2021 13:40 CEST Original file -
article xml uploaded. 8 September 2021 13:40 CEST Update https://www.mdpi.com/2072-6694/13/18/4520/xml
article pdf uploaded. 8 September 2021 13:40 CEST Version of Record https://www.mdpi.com/2072-6694/13/18/4520/pdf
article html file updated 8 September 2021 13:41 CEST Original file -
article html file updated 30 July 2022 04:52 CEST Update https://www.mdpi.com/2072-6694/13/18/4520/html
Back to TopTop